ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Engineering Regulatory T Cells With TCR-Signaling-Responsive Interleukin 2 Nanoparticles Provides In Situ Suppression Of Alloimmunity

    S. K. Eskandari1, M. B. Melo2, I. Sulkaj1, N. Li2, S. Cai1, H. Allos1, J. Y. Choi1, D. J. Irvine2, J. R. Azzi1

    1Harvard Medical School, Brigham and Women's Hospital, Boston, MA, 2David H. Koch Institute for Integrative Cancer Research, Cambridge, MA

    *Purpose: Adoptive cell transfer of regulatory T cells (TReg) has shown great potential in animal models of auto- and alloimmunity. The translation of TReg therapies…
  • 2019 American Transplant Congress

    Development of a Pharmacy Collaborative Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic

    R. Chelewski1, K. Johnson1, A. Zuckerman2, J. DeClercq3, L. Choi3, M. Peter2, A. J. Langone4

    1Vanderbilt Specialty Pharmacy Services, Vanderbilt Univ Medical Ctr, Nashville, TN, 2Department of Pharmacy, Vanderbilt Univ Medical Ctr, Nashville, TN, 3Department of Biostatistics, Vanderbilt Univ Medical Ctr, Nashville, TN, 4Division of Nephrology, Vanderbilt Univ Medical Ctr, Nashville, TN

    *Purpose: This study describes the development of a Collaborative Pharmacy Practice Agreement (CPPA) between transplant pharmacists and physicians and assesses change in prescription volume and…
  • 2019 American Transplant Congress

    Three-Year Outcomes of Highly-Sensitized Kidney Transplant Recipients Desensitized with Imlifidase (IdeS)

    E. Huang1, J. Choi1, A. Vo1, A. Peng1, R. Najjar1, S. Sethi1, C. Kjellman2, L. Winstedt2, N. Ammerman1, S. C. Jordan1

    1Cedars Sinai Medical Center, Los Angeles, CA, 2Hansa Medical, Lund, Sweden

    *Purpose: The HLA-incompatible (HLAi) barrier has been traversed using desensitization therapies with IVIg, rituximab and/or plasmapheresis, although antibody-mediated rejection (ABMR) continues to be observed in…
  • 2019 American Transplant Congress

    Effect of Chronic Kidney Disease on Allo-Immune Response in Mice

    P. D. Winterberg1, H. Li1, M. E. Wagener2, M. L. Ford2

    1Pediatrics, Emory University School of Medicine, Atlanta, GA, 2Surgery, Emory University School of Medicine, Atlanta, GA

    *Purpose: Accumulation of memory T cells bearing markers of sustained antigen stimulation have been described in patients with chronic kidney disease (CKD). However, mouse models…
  • 2019 American Transplant Congress

    In Vitro Model to Study the Effect of Irradiation Preconditioning on Alloimmune Responses: Development of Potential Predictive Markers

    K. Shimozawa, K. Janec, L. Contreras-Ruiz, E. C. Guinan

    Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA

    *Purpose: Pre-conditioning using total body irradiation prior to HSCT is a well-established regimen for patients with hematological malignancy. However, irradiation (IR) elicits not only immunosuppressive…
  • 2019 American Transplant Congress

    Development of Non-Human Leukocyte Antigen Antibodies in Cardiac Antibody-Mediated Rejection

    S. B. See1, B. S. Mantell2, K. J. Clerkin3, B. Ray4, E. R. Vasilescu5, C. Marboe5, Y. Naka6, S. Restaino1, P. C. Colombo3, L. J. Addonizio2, M. A. Farr3, E. Zorn1

    1Columbia Center for Translational Immunology, Columbia University, New York, NY, 2Department of Pediatrics, Columbia University, New York, NY, 3Division of Cardiology, Columbia University, New York, NY, 4Immucor, Georgia, GA, 5Department of Pathology and Cell Biology, Columbia University, New York, NY, 6Department of Surgery, Columbia University, New York, NY

    *Purpose: Antibody-mediated rejection (AMR), mainly driven by the development of donor-specific antibodies (DSA) directed against mismatched donor class I and class II HLA, is a…
  • 2019 American Transplant Congress

    Efficacy of Photobiomodulatory Therapy Combined with Short-Term Immunosuppressants Prolonged Allograft Survival in a Rodent Hind-Limb Model

    Y. KUO1, Y. Li1, C. Chen1, R. Chen11, G. Brandacher2

    1Division of Plastic Surgery, Department of Surgery,, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2Department of Plastic Surgery, VCA center, Johns Hopkins University, Baltimore, MD

    *Purpose: Photobiomodulation has been applied for accelerating the skeletal muscle repair process. Our formal study demonstrated vitamin D could be involved in allograft survival and…
  • 2019 American Transplant Congress

    Uterine Graft Procurement in a Living Donor

    L. Johannesson, A. Wall, J. Bayer, G. J. McKenna, G. Testa

    Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

    *Purpose: Uterus transplantation is a new treatment option for females with uterine factor infertility and a rapidly evolving field of organ transplantation. Proof-of-concept, i.e., birth…
  • 2019 American Transplant Congress

    Alpha-1 Antitrypsin Reduces Liver Ischemia Reperfusion Injury during Ex-Vivo Normothermic Machine Perfusion

    D. Detelich1, R. de Vries1, C. Carroll1, M. Stein2, K. Uygun1, H. Yeh1, J. Markmann1

    1Massachusetts General Hospital, Boston, MA, 2Kamada, Rehovot, Israel

    *Purpose: Normothermic machine perfusion is an emerging preservation method in liver transplantation with vast potential as a platform for ex-vivo graft reconditioning. Alpha-1 Antitrypsin (AAT)…
  • 2019 American Transplant Congress

    Multi-omic Analysis Of Hepatic Ischemia/reperfusion Injury Identifies Novel Targets To Mitigate Hepatocellular Damage

    S. Duarte1, V. Boominathan2, Z. Huo3, A. Kobayashi2, U. Kim2, Y. Lai2, A. Coito1, A. Zarrinpar2

    1Surgery, UCLA, Los Angeles, CA, 2Surgery, University of Florida, Gainesville, FL, 3Biostatistics, University of Florida, Gainesville, FL

    *Purpose: Hepatic ischemia/reperfusion injury (IRI) is a major risk factor for acute rejection and early graft dysfunction in liver transplantation. The large and complex landscape…
  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences